Webinar Replays
Below is a collection of our previously recorded webinar sessions, covering different topics from across the industries. If you would like to register for one of our upcoming webinars, please visit the upcoming webinars section.
In Depth Analysis of Particle Contamination for Parenteral Drug Products
This webinar is designed for individuals involved in the manufacturing of parenteral drug products and identified commonly found contaminants in parenteral drug products, how these contaminants are introduced into the manufacturing process and how they can be detected both visibly and non-visibly.
The Value of Presumptive Screening of Physical Evidence
This webinar was designed for police and attorneys and discussed the advantages of microscopic and presumptive screenings of physical evidence, and provided examples of such screenings.
Introduction to Industrial Forensics
This webinar discussed the various areas of an industrial forensics investigation, including contamination testing to control contamination of raw materials, processes and products; different types of quality control systems; and took the audience into the lab to discuss how to prepare samples for testing using various analytical techniques including microscopy, SEM/EDS, FTIR and Raman […]
Intro to Forensic Analysis for Civil Product Liability Claims
This webinar provided an overview of product liability testing, discussed basic analytical testing methods and technologies used for testing different types of materials[...]
Working to Address the Critical Path Opportunity for Generic Nasal Spray Suspensions
This webinar is designed for generic drug manufacturers of nasal spray suspensions. During this webinar, our presenters will discuss how the method of Ingredient-Specific Particle Sizing (ISPS) using Raman Chemical Imaging (RCI) developed by Gateway Analytical, can address the critical path opportunity by providing the accurate and precise drug particle size measurement to demonstrate bioequivalence. Using this method, generic nasal spray suspension developers have the potential to save considerable time and money by waiving the in vivo biostudies.
